{
    "name": "setmelanotide",
    "comment": "Rx",
    "other_names": [
        "Imcivree"
    ],
    "classes": [
        "Melanocortin Agonists"
    ],
    "source": "https://reference.medscape.com/drug/imcivree-setmelanotide-4000110",
    "pregnancy": {
        "common": [
            "Discontinue when pregnancy is recognized, unless benefits of therapy outweigh potential fetal risks",
            "Data are unavailable regarding use in pregnant females to inform a drug-associated risk for major birth defects and miscarriage, or adverse maternal or fetal outcomes",
            "For the general US population, weight loss offers no potential benefit to pregnant women and may result in fetal harm"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "Setmelanotide was not teratogenic when administered to pregnant rats or rabbits at doses 11 and 7 times the maximum recommended human dose, respectively"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "Maternal obesity increases risk for congenital malformations, including neural tube defects, cardiac malformations, oral clefts, and limb reduction defects",
                    "Additionally, weight loss during pregnancy may result in fetal harm, including increased risk of small for gestational age",
                    "Appropriate weight gain based on prepregnancy weight is currently recommended for all pregnant females, including those who are already overweight or obese, owing to the obligatory weight gain that occurs in maternal tissues during pregnancy"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Not recommended for use while breastfeeding",
            "Data are unavailable regarding presence in human milk, effects on breastfed infants, or effects on milk production",
            "Setmelanotide is present in the milk of rats; when a drug is present in rat milk, it is likely it will be present in human milk",
            "Additionally, setmelanotide contains the preservative benzyl alcohol; benzyl alcohol is rapidly metabolized by lactating women, and benzyl alcohol exposure in the breastfed infant is unlikely (benzyl alcohol toxicity in premature neonates and low-weight infants reported in NICU)"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Sexual adverse reactions reported; spontaneous penile erections in males and sexual adverse reactions in females occurred in clinical studies; advise patients who have an erection lasting >4 hr to seek emergency medical attention",
                "May cause generalized increased skin pigmentation and darkening of preexisting nevi owing to pharmacologic effects; reversible upon discontinuation; perform a full body skin examination before initiating and periodically during treatment ",
                "Contains benzyl alcohol; not approved for use in neonates or infants; serious adverse reactions including fatal reactions and gasping syndrome reported in premature neonates and low-birth-weight infants who received drugs containing benzyl alcohol as a preservative",
                "Some drugs that target the CNS may cause depression or suicidal ideation; patients with a history of depression or suicidal ideation may be at increased risk for recurrent episodes while taking this medication; monitor patients for new-onset or worsening of depression, suicidal thoughts or behavior, or any unusual changes in mood or behavior; consider discontinuing if patient experiences suicidal thoughts or behaviors or if clinically significant or persistent depression symptoms occur and periodically during treatment to monitor pre-existing and new skin pigmentary lesions"
            ],
            "specific": [
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Setmelanotide has low potential for pharmacokinetic drug-drug interactions related to CYP450 enzymes, transporters, and plasma protein binding"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Injection site reaction",
            "percent": "96"
        },
        {
            "name": "Skin hyperpigmentation",
            "percent": "78"
        },
        {
            "name": "Nausea",
            "percent": "56"
        },
        {
            "name": "Diarrhea",
            "percent": "37"
        },
        {
            "name": "Abdominal pain",
            "percent": "33"
        },
        {
            "name": "Back pain",
            "percent": "33"
        },
        {
            "name": "Fatigue",
            "percent": "30"
        },
        {
            "name": "Vomiting",
            "percent": "30"
        },
        {
            "name": "Depression",
            "percent": "26"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "26"
        },
        {
            "name": "Spontaneous penile erections",
            "percent": "23"
        },
        {
            "name": "Arthralgia",
            "percent": "19"
        },
        {
            "name": "Asthenia",
            "percent": "19"
        },
        {
            "name": "Dizziness",
            "percent": "15"
        },
        {
            "name": "Dry mouth",
            "percent": "15"
        },
        {
            "name": "Dry skin",
            "percent": "15"
        },
        {
            "name": "Insomnia",
            "percent": "15"
        },
        {
            "name": "Vertigo",
            "percent": "15"
        },
        {
            "name": "Alopecia",
            "percent": "11"
        },
        {
            "name": "Chills",
            "percent": "11"
        },
        {
            "name": "Constipation",
            "percent": "11"
        },
        {
            "name": "Influenzalike illness",
            "percent": "11"
        },
        {
            "name": "Muscle spasm",
            "percent": "11"
        },
        {
            "name": "Pain in extremity",
            "percent": "11"
        },
        {
            "name": "Rash",
            "percent": "11"
        },
        {
            "name": "Suicidal ideation",
            "percent": "11"
        },
        {
            "name": "Female sexual adverse reactions",
            "percent": "7"
        }
    ]
}